Cancer Epidemiology Biomarkers & Prevention: 2 (1)

Predictors of future breast cancer risk.

P F Engstrom

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 1-2;
ASPO Distinguished Achievement Award Lecture. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid.

N L Petrakis

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 3-10;
Canadian National Breast Screening Study: first screen results as predictors of future breast cancer risk.

P H Holowaty, A B Miller, C J Baines and H Risch

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 11-19;
The effect of alcohol on the risk of lung cancer in Uruguay.

E De Stefani, P Correa, L Fierro, E T Fontham, V Chen and D Zavala

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 21-26;
Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.

A W Hsing and G W Comstock

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 27-32;
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer.

G B Gordon, K J Helzlsouer, A J Alberg and G W Comstock

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 33-35;
Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk.

D Palli, A Decarli, F Cipriani, F Sitas, D Forman, D Amadori, C Avellini, A Giacosa, P Manca and A Russo

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 37-40;
Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps.

L C Clark, L J Hixson, G F Combs Jr, M E Reid, B W Turnbull and R E Sampliner

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 41-46;
Urinary trans,trans-muconic acid as an indicator of exposure to benzene in cigarette smokers.

A A Melikian, A K Prahalad and D Hoffmann

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 47-51;
Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene.

G Cosma, F Crofts, D Currie, I Wirgin, P Toniolo and S J Garte

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 53-57;
Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers.

R M Santella, K Hemminki, D L Tang, M Paik, R Ottman, T L Young, K Savela, L Vodickova, C Dickey and R Whyatt

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 59-62;
4,4'-Methylene-bis(2-chloroaniline)-DNA adduct analysis in human exfoliated urothelial cells by 32P-postlabeling.

K R Kaderlik, G Talaska, D G DeBord, A M Osorio and F F Kadlubar

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 63-69;
A randomized double-blind intervention study on the effect of calcium supplementation on esophageal precancerous lesions in a high-risk population in China.

L D Wang, S L Qiu, G R Yang, M Lipkin, H L Newmark and C S Yang

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 71-78;
Epidemiology of ovarian cancer.

A R Patel and G I Obrams

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 79-83;
Molecular and biochemical methods in cancer epidemiology and prevention: the path between the laboratory and the population. AACR special conference in cancer research.

P Correa

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 85-88;
Correspondence re: R. T. Falk et al., Epidemiology of bronchioloalveolar carcinoma. Cancer Epidemiol., Biomarkers & Prev., 1: 339-344, 1992.

A Morabia and E L Wynder

Cancer Epidemiol Biomarkers Prev January 1 1993 2 (1) 89-90;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Cancer Epidemiology, Biomarkers & Prevention